ANVISA and the ICH: How Regulatory Harmonization Strengthens the Brazilian Pharmaceutical Sector
Brazil’s participation in the ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use) marks a strategic milestone for the national pharmaceutical industry. This Blog explains what the ICH is, the importance of ANVISA’s presence in this global forum, and how regulatory harmonization drives innovation and access to new treatments in the country.